PubRank

Philippe Gallay

Author PubWeight™ 24.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus. Hepatology 2008 2.24
2 Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem 2002 1.96
3 The isomerase active site of cyclophilin A is critical for hepatitis C virus replication. J Biol Chem 2009 1.79
4 One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. J Virol 2011 1.77
5 DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A. PLoS One 2010 1.59
6 Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc Natl Acad Sci U S A 2007 1.54
7 TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest 2008 1.28
8 Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner. J Virol 2011 1.22
9 Curing a viral infection by targeting the host: the example of cyclophilin inhibitors. Antiviral Res 2013 1.10
10 Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120. Retrovirology 2006 1.08
11 Cyclophilin inhibitors for the treatment of HCV infection. Curr Opin Investig Drugs 2010 1.03
12 The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection. J Hepatol 2012 0.99
13 The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A. J Virol Methods 2010 0.94
14 Preclinical characterization of naturally occurring polyketide cyclophilin inhibitors from the sanglifehrin family. Antimicrob Agents Chemother 2011 0.87
15 Review of the twelfth West Coast Retrovirus Meeting. Retrovirology 2005 0.86
16 PD 404,182 is a virocidal small molecule that disrupts hepatitis C virus and human immunodeficiency virus. Antimicrob Agents Chemother 2011 0.85
17 Cyclophilin inhibitors: an emerging class of therapeutics for the treatment of chronic hepatitis C infection. Viruses 2012 0.79
18 Cyclophilin involvement in the replication of hepatitis C virus and other viruses. Biol Chem 2012 0.79
19 Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide. Antimicrob Agents Chemother 2013 0.75
20 Development and evaluation of an enzyme-linked immunosorbent assay for dengue capsid. Open Virol J 2012 0.75